Two-Pronged attack: experimental drug aims to Re-Engage immune system against tough cancers
NCT ID NCT04931654
Summary
This early-stage study is testing a new drug called AZD7789 in people with advanced lung or stomach cancers that have spread and stopped responding to standard immunotherapy. The main goals are to find a safe dose and see if the drug shows any signs of shrinking tumors. The drug is designed to block two different 'off-switches' on immune cells at once, hoping to help the body's own defenses fight the cancer more effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Atlanta, Georgia, 30322, United States
-
Research Site
Fort Wayne, Indiana, 46804, United States
-
Research Site
New York, New York, 10029, United States
-
Research Site
Nashville, Tennessee, 37203, United States
-
Research Site
Toronto, Ontario, M5G 2M9, Canada
-
Research Site
Beijing, 100142, China
-
Research Site
Guangzhou, 510060, China
-
Research Site
Bordeaux, 33076, France
-
Research Site
Rennes, 35000, France
-
Research Site
Villejuif, 94805, France
-
Research Site
Tbilisi, 0112, Georgia
-
Research Site
Chūōku, 104-0045, Japan
-
Research Site
Kashiwa, 277-8577, Japan
-
Research Site
Chisinau, MD-2025, Moldova
-
Research Site
Amsterdam, 1066 CX, Netherlands
-
Research Site
Barcelona, 08035, Spain
-
Research Site
Madrid, 28027, Spain
-
Research Site
Ankara, 06010, Turkey (Türkiye)
-
Research Site
Ankara, 06200, Turkey (Türkiye)
-
Research Site
Ankara, 06800, Turkey (Türkiye)
-
Research Site
Cordaleo, 35575, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.